You are here

Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Montgomery, Alabama, 36117 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoarthritis, Arthritis, Pain
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of osteoarthritis (OA) of the knee according to American College of
Rheumatology (ACR) criteria with a Kellgren- Lawrence score of greater than or equal
to 2

- 18 years of age or greater

- Two methods of birth control one of which must be barrier if of childbearing potential

- Willing to discontinue pain medication except as permitted per protocol

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnancy or wishing to be pregnant during the course of the study, lactating women

- Body Mass Index (BMI) greater than 39

- Clinically significant cardiac, neurological, psychiatric conditions and other
conditions that are excluded by the protocol.

- Previous exposure to a Nerve Growth Factor (NGF) antibody

NCT01089725
Pfizer
Terminated
Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriatic Arthritis
NCT03486457
All Genders
18+
Years
Multiple Sites
Rheumatoid Arthritis
NCT03992781
All Genders
Rheumatoid Arthritis
NCT03981900
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now